Best Biotech Stocks Based on Genetic Algorithms: Returns up to 9.10% in 3 Days

Best Biotech Stocks

The BioTech Stocks Package is designed for investors and analysts who need predictions of the best stocks to buy for the whole Biotechnology Industry. It includes 20 stocks with bullish and bearish signals and indicates the best biotech stocks to trade:

  • Top 10 Biotech stocks for the long position
  • Top 10 Biotech stocks for the short position

BioTech Stocks
Package Name: BioTech Stocks
Recommended Positions: Long
Forecast Length: 3 Days (11/20/2018 – 11/23/2018)
I Know First Average: 2.37%
Best Biotech Stocks

7 out of 10 stock prices in this forecast for the BioTech Stocks Package moved as predicted by the algorithm. INVA was our best stock pick this week a return of 9.10%. AKRX and RDY followed with returns of 5.90% and 4.96% for the 3 Days period. The package saw an overall yield of 2.37% versus the S&P 500’s return of -2.16% implying a market premium of 4.53%.

Innoviva, Inc., formerly Theravance, Inc., incorporated on November 19, 1996, focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals. It focuses on the respiratory assets partnered with Glaxo Group Limited (GSK), including RELVAR/BREO ELLIPTA (fluticasone furoate (FF)/vilanterol (VI)) and ANORO ELLIPTA (umeclidinium bromide/vilanterol (UMEC/VI)).

Under the Long-Acting Beta2 Agonist (LABA) Collaboration Agreement and the Strategic Alliance Agreement with GSK, the Company is eligible to receive the annual royalties from GSK on sales of RELVAR/BREO ELLIPTA. For other products combined with a LABA from the LABA collaboration, such as ANORO ELLIPTA, royalties are upward tiering and range from 6.5% to 10%. The Company is also entitled to approximately 15% of any future payments made by GSK under its agreements originally entered into with it, and since assigned to Theravance Respiratory Company, LLC (TRC). RELVAR/BREO is a once-a-day combination inhaled respiratory medicine consisting of a LABA (VI) and an inhaled corticosteroid (ICS), FF. ANORO ELLIPTA a once-daily medicine combining a long-acting muscarinic antagonist (LAMA), umeclidinium bromide (UMEC), with a LABA.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

How to interpret this diagram

Algorithmic Stock Forecast: The table on the left is a stock forecast produced by I Know First’s algorithm. Each day, subscribers receive forecasts for six different time horizons. Note that the top 10 stocks in the 1-month forecast may be different than those in the 1-year forecast. In the included table, only the relevant stocks have been included. The boxes are arranged according to their respective signal and predictability values (see below for detailed definitions). A green box represents a positive forecast, suggesting a long position, while a red represents a negative forecast, suggesting a short position.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.